Plasma fibronectin promotes lung metastasis by contributions to fibrin clots and tumor cell invasion.

The attachment of circulating tumor cells to the blood vessels of distant organs is an important step in metastasis. We show here that experimental lung metastasis by two cell lines, B16F1 melanoma and 3LL lung carcinoma, is greatly reduced in transgenic mice that lack plasma fibronectin. This multifunctional adhesive glycoprotein becomes cross-linked to fibrin during clotting. Here, we report that eliminating plasma fibronectin from the blood circulation reverses the prometastatic effects of blood clotting and tumor cell integrin alphavbeta3. In vitro studies showed that fibrin-fibronectin complexes, but not purified fibrin, supported tumor cell attachment and invasion. These functions correlate with the ability of fibrin-fibronectin complexes to induce the activation of integrin alphavbeta3. Our findings reveal an important contribution of plasma fibronectin in lung metastasis. Furthermore, they suggest that the previously noted effects of blood clotting on lung metastasis might be mediated in part by a fibronectin-alphavbeta3 integrin axis, in which plasma fibronectin has to be incorporated into the blood clot.

[1]  R. Weinberg,et al.  Integrin β1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs , 2009, Proceedings of the National Academy of Sciences.

[2]  B. Garmy-Susini,et al.  Integrins in angiogenesis and lymphangiogenesis , 2008, Nature Reviews Cancer.

[3]  S. Lockett,et al.  Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton. , 2008, Cancer research.

[4]  J. Degen,et al.  Factor XIII transglutaminase supports hematogenous tumor cell metastasis through a mechanism dependent on natural killer cell function , 2008, Journal of thrombosis and haemostasis : JTH.

[5]  P. Reitsma,et al.  Experimental melanoma metastasis in lungs of mice with congenital coagulation disorders , 2008, Journal of cellular and molecular medicine.

[6]  F. Rosenow,et al.  Antimetastatic Integrin as Inhibitors of Snake Venoms , 2008 .

[7]  C. Spek,et al.  Colon cancer metastasis in mouse liver is not affected by hypercoagulability due to Factor V Leiden mutation , 2007, Journal of cellular and molecular medicine.

[8]  A. Hsu,et al.  SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts , 2007, Basic Research in Cardiology.

[9]  C. Chi,et al.  Osteopontin promotes integrin activation through outside-in and inside-out mechanisms: OPN-CD44V interaction enhances survival in gastrointestinal cancer cells. , 2007, Cancer research.

[10]  Dan H. Moore,et al.  Increased β1 Integrin Is Associated with Decreased Survival in Invasive Breast Cancer , 2007 .

[11]  S. Iwata,et al.  Anti-CD26 Monoclonal Antibody–Mediated G1-S Arrest of Human Renal Clear Cell Carcinoma Caki-2 Is Associated with Retinoblastoma Substrate Dephosphorylation, Cyclin-Dependent Kinase 2 Reduction, p27kip1 Enhancement, and Disruption of Binding to the Extracellular Matrix , 2006, Clinical Cancer Research.

[12]  Ruth J. Muschel,et al.  Coagulation Facilitates Tumor Cell Spreading in the Pulmonary Vasculature during Early Metastatic Colony Formation , 2004, Cancer Research.

[13]  Liang Hu,et al.  Role of endogenous thrombin in tumor implantation, seeding, and spontaneous metastasis. , 2004, Blood.

[14]  E. Ruoslahti,et al.  Metadherin, a cell surface protein in breast tumors that mediates lung metastasis. , 2004, Cancer cell.

[15]  D. Calderwood Integrin activation , 2004, Journal of Cell Science.

[16]  B. Pauli,et al.  A Novel Consensus Motif in Fibronectin Mediates Dipeptidyl Peptidase IV Adhesion and Metastasis* , 2003, Journal of Biological Chemistry.

[17]  D. Jackson,et al.  Spontaneous hematogenous and lymphatic metastasis, but not primary tumor growth or angiogenesis, is diminished in fibrinogen-deficient mice. , 2002, Cancer research.

[18]  C. Rüegg,et al.  Prostaglandin E2 Promotes Integrin αVβ3-dependent Endothelial Cell Adhesion, Rac-activation, and Spreading through cAMP/PKA-dependent Signaling* , 2002, The Journal of Biological Chemistry.

[19]  C. Ohyama,et al.  Sialyl Lewis X-dependent lung colonization of B16 melanoma cells through a selectin-like endothelial receptor distinct from E- or P-selectin. , 2002, Cancer research.

[20]  J. Pilch,et al.  Unique Ability of Integrin αvβ3 to Support Tumor Cell Arrest under Dynamic Flow Conditions* 210 , 2002, The Journal of Biological Chemistry.

[21]  Kamin J. Johnson,et al.  Plasma fibronectin supports neuronal survival and reduces brain injury following transient focal cerebral ischemia but is not essential for skin-wound healing and hemostasis. , 2001, Nature Medicine.

[22]  J W Smith,et al.  Integrin activation controls metastasis in human breast cancer. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[23]  A. Stamford,et al.  Inhibition of cellular action of thrombin by N3-cyclopropyl-7-[[4-(1-methylethyl)phenyl]methyl]-7H-pyrrolo[3, 2-f]quinazoline-1,3-diamine (SCH 79797), a nonpeptide thrombin receptor antagonist. , 2000, Biochemical pharmacology.

[24]  T. Bugge,et al.  Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells. , 2000, Blood.

[25]  Philip E. Dawson,et al.  Presentation of chemokine SDF-1α by fibronectin mediates directed migration of T cells , 2000 .

[26]  T. Byzova,et al.  A mechanism for modulation of cellular responses to VEGF: activation of the integrins. , 2000, Molecular cell.

[27]  Eric S. Lander,et al.  Genomic analysis of metastasis reveals an essential role for RhoC , 2000, Nature.

[28]  S. Altschul,et al.  A public database for gene expression in human cancers. , 1999, Cancer research.

[29]  G. Nemerow,et al.  Mechanisms and Consequences of Affinity Modulation of Integrin αVβ3 Detected with a Novel Patch-engineered Monovalent Ligand* , 1999, The Journal of Biological Chemistry.

[30]  J. Sottile,et al.  Identification of Protein-disulfide Isomerase Activity in Fibronectin* , 1999, The Journal of Biological Chemistry.

[31]  D. Essex,et al.  Protein disulphide isomerase mediates platelet aggregation and secretion , 1999, British journal of haematology.

[32]  M. Paulsson,et al.  Tissue Transglutaminase and Factor XIII in Cartilage and Bone Remodeling , 1996, Seminars in thrombosis and hemostasis.

[33]  J. Schwarzbauer,et al.  Changes in cell spreading and cytoskeletal organization are induced by adhesion to a fibronectin-fibrin matrix. , 1996, Blood.

[34]  M. Ginsberg,et al.  Beta 3 integrin-mediated fibrin clot retraction by nucleated cells: differing behavior of alpha IIb beta 3 and alpha v beta 3. , 1995, Blood.

[35]  J. Martínez,et al.  An anti-alpha v-integrin antibody that blocks integrin function inhibits the development of a human melanoma in nude mice. , 1995, Journal of cell science.

[36]  S. Karpatkin,et al.  Role of Platelets, Thrombin, Integrin llb-llla, Fibronectin and Von Willebrand Factor on Tumor Adhesion in Vitro and Metastasis in Vivo , 1995, Thrombosis and Haemostasis.

[37]  M. Hurme,et al.  Comparison of retinoic acid and phorbol myristate acetate as inducers of monocytic differentiation , 1994, International journal of cancer.

[38]  R. Alon,et al.  TNF-alpha binds to the N-terminal domain of fibronectin and augments the beta 1-integrin-mediated adhesion of CD4+ T lymphocytes to the glycoprotein. , 1994, Journal of immunology.

[39]  E. Ruoslahti,et al.  Superfibronectin is a functionally distinct form of fibronectin , 1994, Nature.

[40]  M. Rocco,et al.  Solution structure of human plasma fibronectin under different solvent conditions. Fluorescence energy transfer, circular dichroism and light-scattering studies. , 1993, Journal of molecular biology.

[41]  D. Cheresh,et al.  Involvement of integrin alpha V gene expression in human melanoma tumorigenicity. , 1992, The Journal of clinical investigation.

[42]  S. Jalkanen,et al.  Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin , 1992, The Journal of cell biology.

[43]  M. Humphries,et al.  A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells. , 1986, Science.

[44]  E. Gorelik,et al.  Role of nk cells in the antimetastatic effect of anticoagulant drugs , 1984, International journal of cancer.

[45]  F. Rosenow,et al.  Integrins as antimetastatic targets of RGD-independent snake venom components in liver metastasis [corrected]. , 2008, Neoplasia.

[46]  稲元 輝生 Anti-CD26 monoclonal antibody-mediated G1-S arrest of human renal clear cell carcinoma Caki-2 is associated with retinoblastoma substrate dephosphorylation, cyclin-dependent kinase 2 reduction, p27[kip1] enhancement, and disruption of binding to the extracellular matrix , 2007 .

[47]  J. Degen,et al.  Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. , 2005, Blood.

[48]  R. Juliano,et al.  Integrin Signaling , 2005, Cancer and Metastasis Reviews.

[49]  E. Ruoslahti Fibronectin in cell adhesion and invasion , 2004, Cancer and Metastasis Reviews.

[50]  Cynthia,et al.  Involvement of Integrin aV Gene Expression in Human Melanoma Tumorigenicity , 2003 .

[51]  E. Ruoslahti,et al.  Fibronectin and its integrin receptors in cancer. , 1999, Advances in cancer research.

[52]  K. Honn,et al.  Enhanced endothelial cell retraction mediated by 12(S)-HETE: a proposed mechanism for the role of platelets in tumor cell metastasis. , 1994, Experimental cell research.

[53]  E. Engvall,et al.  Fibronectin: purification, immunochemical properties, and biological activities. , 1982, Methods in enzymology.